NASDAQ:RVNC

Revance Therapeutics Stock Predictions

NASDAQ Stock Exchange > Healthcare > Biotechnology

Open Broker Account

$3.95

+0.180 (+4.77%)

At Close: May 03, 2024

Currently predicting for Mon, 6 May 2024

Trading levels for RVNC

Fibonacci Support & Resistance Levels

		Level	Price
	Resistance	R3	4.16	5.23 %
		R2	4.08	3.39 %
		R1	4.04	2.26 %
Current price:			3.95
	Support	S1	3.89	-1.42 %
		S2	3.85	-2.55 %
		S3	3.78	-4.39 %

Accumulated Volume Support & Resistance Levels

		Level	Price
	Resistance	R3	4.69	18.73 %
		R2	4.41	11.65 %
		R1	3.97	0.506 %
Current price			3.95
	Support	S1	3.81	-3.54%
		S2	3.69	-6.58%
		S3	3.29	-16.71%

RVNC Predictions History

2 years ago
JS predicted that RVNC for 2022-03-29 is going $19.92 (-1.92%)

About Revance Therapeutics

Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection, which has completed phase III clinical trials for the treatment of glabellar (frown) lines and cervical dystonia; is in phase II clinical trials to tre... RVNC Profile

Golden Star

Ticker	Date	Change	Price
CVBF	May 01	2.75%	$16.75
FTSL	May 01	0.282%	$46.03
EQC	Apr 30	0.694%	$18.72
HRB	Apr 30	0.635%	$47.23
BSCQ	Apr 30	0.576%	$19.09
BSJP	Apr 29	0.306%	$22.91
LYG	Apr 29	1.56%	$2.56
ORA	Apr 29	4.68%	$64.48
DHT	Apr 24	3.10%	$11.28
LPLA	Apr 19	3.12%	$262.59

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by

Sign In